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330a Monday, February 27, 2012Our data suggest that re-assessment of mechanisms underlying hERG activa-
tion gating is required, particularly with regard to the coupling mechanisms be-
tween voltage sensor movement and channel pore opening.
1 Es-Salah-Lamoureux et al., 2010, PLoS One 28;5(5):e10876
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Reduction of the current carried by the cardiac potassium channel HERG can
lead to Long QT syndrome, an arrhythmia characterized by a rapid heart rate
and reduced cardiac output, which can, in certain situations, be fatal. The effect
of extracellular electrolytes on the biophysical properties of the HERG channel
have been studied in some detail. In particular, increases in extracellular cal-
cium, magnesium and hydrogen have been shown to slow channel deactivation.
In addition, a number of reports have also shown that hydrogen can reduce
HERG current by a mechanism that does not involve an effect on channel de-
activation and which may involve pore block. We show here that reducing ex-
tracellular potassium results in a significant increase in HERG current
reduction by both extracellular calcium and hydrogen. The Drosophila
voltage-gated potassium channel Shaker, showed a much smaller decrease in
current by extracellular calcium and this effect was not dependent on extracel-
lular potassium. Furthermore, the reduction in HERG current by extracellular
hydrogen depended on the extracellular calcium concentration. Taken together
these results suggest that calcium and hydrogen can block the HERG potassium
channel and that calcium, hydrogen, and potassium may interact at the outer
pore of the HERG channel. These extracellular electrolyte effects may be spe-
cific to the HERG channel.
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Drug-induced prolongation of the QT interval via hERG block is a major cause
of attrition in drug development. The advent of automated electrophysiology
systems has greatly reduced this risk by enabling the detection of hERG block
earlier in drug discovery. In this study, we have evaluated the suitability of the
IonWorks Barracuda for the characterization of hERG biophysics and pharma-
cology. The IonWorks Barracuda is a second generation automated patch
clamp system with increased throughput and capabilities, allowing 384 parallel
recordings and up to 8 additions per recording. All experiments were conducted
with CHO cells stably expressing hERG. Recordings were made in population
patch clamp mode, where each current is measured from an average of up to 64
cells. We first examined hERG gating characteristics. HERG V1/2 for activa-
tion was7.85 1.8 mV (n=183) on the IonWorks Barracuda versus 17.55
5.3 mV (n=9) by manual patch clamp. For pharmacological experiments, all
drug additions were made in a cumulative fashion such that up to 384 dose-
responses could be obtained in a single experiment. Seal resistances and cur-
rents were stable (<20% change) with up to 6 additions and 1-minute incuba-
tions per addition. Over 27 experiments, 96% of the recordings yielded full
dose-response curves. HERG pharmacology was examined with a set of 353
compounds that included well-characterized hERG blockers. Astemizole, terfe-
nadine and quinidine inhibited hERG currents with IC50 values of 159 nM, 224
nM and 2 microM, respectively (n=51, 10 & 18). This set of compounds was
also tested with the PatchXpress automated electrophysiology system. We de-
termined through statistical methods that the two automated systems provided
equivalent results. In conclusion, this study showed that hERG biophysical and
pharmacological characterizations can be conducted very efficiently with the
IonWorks Barracuda.
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The voltage-gated ether-a-go-go (EAG) potassium channel family plays an im-
portant role in cardiac and neuronal repolarization, tumor proliferation and hor-
mone secretion. These channels are tetrameric, with six transmembrane helicesper subunit and large N- and C-terminal cytoplasmic domains. The function of
the cytoplasmic domains remains unclear, but it is thought that they are in-
volved in channel regulation since they can be phosphorylated and can interact
with kinases, integrins and calmodulin. In particular, the C-terminal domain has
strong homology to cyclic nucleotide binding domains (CNBDs) but it has been
demonstrated that EAG channel function is not affected by cyclic nucleotides
and that the domain does not bind nucleotides, in vitro. I have determined the
2.2 A˚ X-ray structure of one of these domains from the mouse EAG1 channel;
the structure has the canonical CNBD fold but it shows a ligand pocket that has
several differences relative to a cyclic nucleotide binding site, shedding some
light into why these domains are not able to bind cyclic nucleotides. Here I
present the biochemical characterization of this domain, a first step in the un-
derstanding the role of the C-terminal cytoplasmic domain in channel
regulation.
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Hyperpolarization-activated cyclic nucleotide-regulated (HCN) channels are
pace-making channels that contribute to rhythmic activity in the heart and
brain. All HCN-family channels contain a large intracellular domain in their
carboxy terminal region which includes a cyclic nucleotide binding domain
(CNBD) and a C-linker that connects it to the pore. We recently reported
that the flavonoids luteolin and myricetin regulate Eag1 channels by binding
a domain in their carboxy-terminal region that shares sequence and structural
similarity with the CNBD of HCN2. In a screen of flavonoids, we identified
fisetin as another potent regulator of Eag1. Fisetin shifted the voltage-
dependence of Eag1 channels toward more hyperpolarizing potentials and
slowed channel deactivation. Here we demonstrate that fisetin also regulates
the kinetic and steady state properties of HCN2 channels. We found that
30 mM fisetin sped activation at 140 mV, decreasing the time constant
from 1.17 5 0.10 s to 0.80 5 0.8 s (N=10). Additionally, 30 mM fisetin
shifted the Vhalf of the conductance-voltage relationship from 127.8 5
0.7 mV, to 120.4 5 0.7 mV (N=10). Fisetin shifted the voltage-
dependence of Eag and HCN channels in opposite directions, indicating that
it is not simply interacting with the voltage sensor. Furthermore we found
that fisetin and cAMP had non-additive effects on HCN2 channel gating. Us-
ing a FRET-based binding assay, we showed that fisetin bound to the purified
CNBD of HCN2. Additionally, fisetin did not speed activation or shift the
voltage-dependence of HCN2 channels lacking their CNBD. Together these
data indicate that the CNBD mediates fisetin regulation of HCN2 channels.
Based on the similar regulation of Eag and HCN channels by fisetin we pro-
pose that the mechanisms underlying ligand-mediated gating is well-
conserved amongst these channels.
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The Human Ether-a´-go-go Related Gene (hERG) encodes a voltage-activated
Kþ channel. hERG contributes to the repolarization of the ventricular action
potential as part of the IKr current and has also been shown to modulate neuro-
nal firing frequency. hERG gating is characterized by rapid inactivation upon
depolarization and rapid recovery from inactivation and slow closing (deactiva-
tion) upon repolarization. These factors combine to create a resurgent hERG
current, where the current amplitude is paradoxically larger with repolarization
than with depolarization. Previous data have shown that the N-terminal region
of hERG regulates gating kinetics, however the molecular mechanisms of this
regulation are not fully understood. Deletion of the hERG N-terminus (amino
acids 2-354) has been shown to speed channel deactivation and recovery from
inactivation compared to that of wild-type hERG channels. Relative outward
current amplitude is also increased during the depolarization phase, leading
to reduced current rectification. A genetically encoded eag domain fragment
(amino acids 1-135) was shown to restore slow deactivation to N-truncated
channels by forming a stable interaction with the C-terminal cyclic nucleotide
binding domain (CNBD). Our present study sought to further investigate the
contributions of the eag domain and proximal N-terminal region (amino acids
136-354) to hERG gating kinetics. We coexpressed genetically encoded N-ter-
minal region fragments with hERG channels bearing a deletion of the full
N-terminus (D2-354) or the eag domain (D2-135) in Xenopus oocytes and mea-
sured current with two-electrode voltage-clamp recordings. Here we report that
